Nipro (8086.T) Stock Price

Nipro Price

JPX·CLOSED
1,342.50
​
Market closed

Revenue has compounded at 6.9% per year over the past 19 years to 660.54 B JPY. Earnings per share have grown at 2.4% per year over the last 19 years. Nipro's net margin stands at 2.0%, broadly stable from 2.7% several years earlier. Nipro currently offers a dividend yield of about 3.05%. The payout ratio is around 67% of earnings. The dividend has grown at 1.2% per year over the past 19 years. Analysts set a median price target of 1,326.00 JPY, implying 1.2% below the current price. Of 9 analysts, 5 rate the stock a buy — an overall Buy consensus.

Nipro stock price

Access this data via the Eulerpool API

Nipro business model & stock analysis

Nipro Corp is a Japanese company that was originally founded under the name Niki Shoji. The company was established in 1954 and initially produced steel pipes and accessories. In 1964, the company changed its name to Nipro Corp and expanded its business to the production of medical devices and instruments. Since then, Nipro Corp has become a major player in the global market for medical products and services. The business model of Nipro Corp is based on the design, manufacturing, and sale of a wide range of medical products, including dialysis machines, artificial organs, blood glucose meters, and infusion devices. The company is also active in the pharmaceutical and healthcare industries, offering various related services such as clinical trials. Nipro Corp is divided into various divisions, including Nipro Medical Corporation, which produces and sells the company's medical product range. This division is divided into three departments: dialysis technology, transfusion and infusion department, and the artificial organs department, which includes various products such as heart-lung machines and artificial kidneys. Another important division is Nipro Pharma Corporation, which focuses on the development, manufacturing, and sale of pharmaceuticals. The company has a strong presence in this division in the Asian market and is currently expanding into Europe and the United States. Another important area in which Nipro Corp is active is the manufacturing of glass and plastic products, particularly glass ampoules for storing medications and plastic products for medical use. In addition to its main business areas, Nipro Corp also offers a wide range of products and services for environmental technology, the semiconductor industry, and the electronics industry. The company is also involved in the production of solar energy products and has filed various patents in this field. Innovation and quality control are two important focuses of Nipro Corp. The company is heavily dedicated to researching and developing new products and technologies, as well as building strong business relationships with its customers. One of the key strategies of the company is to align its research and development activities with the needs of its customers and end-users to ensure that its products meet their requirements and expectations. Another focus of Nipro Corp is quality assurance and control. The company has a strict quality management system that is applied in all stages of the manufacturing process to ensure that its products meet the highest international standards. Overall, Nipro Corp has become a major player in the global market for medical products and services. With its wide range of products and services, focus on innovation and quality, and strong presence in the Asian market, the company is in a strong position to continue growing and evolving.

Frequently asked questions about Nipro

Nipro Corp, a leading Japanese company, operates in the healthcare industry, focusing on medical equipment and pharmaceutical products. With a diverse business model, Nipro Corp manufactures and sells various medical devices, including renal and infusion solutions, blood purification systems, and diabetes care products. Their pharmaceutical division is involved in the development and sales of generic drugs and therapeutic pharmaceuticals. Through strategic partnerships and acquisitions, Nipro Corp continues to expand its global presence and enhance its product offerings. As a renowned healthcare company, Nipro Corp remains committed to improving patient outcomes and contributing to the advancement of medical science worldwide.

Nipro Corp is primarily active in the healthcare industry.

The main competitors of Nipro Corp in the market include Medtronic, Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, and Fresenius Medical Care.

Nipro Corp is a leading Japanese company in the healthcare sector. Founded in 1954, it has a rich history and strong background. Nipro Corp initially started as a manufacturer of medical devices, specializing in hypodermic needles and syringes. Over the years, the company expanded its product portfolio to include a wide range of medical equipment, pharmaceuticals, and renal products. Nipro Corp has established itself as a global player, serving healthcare professionals and patients worldwide. With a commitment to innovation and quality, Nipro Corp continues to contribute to the advancement of healthcare technologies and improve the lives of people globally.

Nipro Corp, a renowned company, has achieved several significant milestones throughout its history. The company has successfully established a global presence in the healthcare industry through its innovative solutions and dedication to excellence. Nipro Corp has made key advancements in the development of medical devices, pharmaceuticals, and renal products, positioning itself as a leader in these sectors. Furthermore, Nipro Corp has achieved notable accomplishments in expanding its market reach, enhancing its product portfolio, and fostering strategic collaborations. The company's commitment to continual growth and improvement has enabled it to leave a lasting impact on the healthcare field, making it a trusted and respected name in the industry.

Nipro Corp is primarily present in various countries and regions across the globe. The company has a strong international presence, with its main operations centered in Japan, its home country. Additionally, Nipro Corp actively conducts business in North America, Europe, Asia, and other parts of the world. With a diversified geographical reach, Nipro Corp aims to serve a wide range of customers and expand its market presence globally.

Nipro Corp is a leading company globally, known for its strong corporate philosophy and values. The company represents a commitment to innovation, quality, and sustainability in the healthcare industry. Nipro Corp aims to enhance patients' lives through advanced medical technologies, including dialysis products, medical devices, and pharmaceuticals. With a focus on patient-centric care, Nipro Corp strives to ensure the highest standards of safety, effectiveness, and affordability in their products. The company's core values emphasize integrity, teamwork, and social responsibility. Nipro Corp continuously endeavors to contribute to society and improve healthcare outcomes worldwide.

Analysts currently set an average price target of 1,470.84 JPY for the Nipro stock (median: 1,326.00 JPY), implying +9.6 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Nipro stock: 5 recommend buying, 3 holding and 1 selling.

Converted at the current exchange rate, the Nipro share trades at 7.59 EUR (1,342.50 JPY).

The Nipro share (8086.T) is listed on 4 stock exchanges, including: Tokio (JPX) (8086.T), Frankfurt (5FA.F), München (5FA.MU), Düsseldorf (5FA.DU).

The Nipro Corporation is a Japanese company that operates in various industries. Founded in 1954, the company has become a global player, offering a wide range of products and services. One of the company's main activities is the manufacturing of medical products. Thanks to advanced technology and extensive research and development, Nipro is able to offer its customers a variety of high-quality products that are used in both clinical and home environments. Nipro's medical products include infusion and dialysis devices, insulin pumps and injectors, blood glucose meters, catheters, stents, and other medical devices. Additionally, the company also offers a wide range of pharmaceutical products used to treat various diseases and ailments. In addition to healthcare, Nipro is also involved in other industries. For example, the company has a division for electronics products, including touchscreens, LED lighting technology, and energy storage systems. Here too, the company strives to develop innovative technologies and offer its customers high-quality products. Nipro is also active in the food industry, offering a wide range of natural foods and beverages. The company places special emphasis on sustainability and environmental friendliness, employing organic farming methods and resource-efficient production processes. Another important area for Nipro is environmental technology. The company develops and produces photovoltaic modules to harness renewable energies and water purification systems that enable sustainable water usage. In addition to product manufacturing, Nipro also provides consulting services to customers in various industries. The company supports its customers in the development of new products or services and helps optimize business processes. Overall, Nipro's business model is highly diversified, encompassing various industries and divisions. The company is committed to developing innovative technologies and offering its customers high-quality products and services. It also emphasizes sustainability and environmental friendliness, taking its responsibility towards society and the environment seriously.

The revenue of Nipro is 660.54 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of Nipro is 13.50 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nipro is currently 18.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nipro stock.

The price-to-sales ratio (P/S) of Nipro is currently 0.37. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nipro stock.

The Eulerpool Quality Score for Nipro is 5/10.

The ISIN of Nipro is JP3673600007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Nipro is 875746. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Nipro is 8086.T. The ticker symbol is used to trade Nipro shares on the stock exchange.

Fair ValueTerminal
1,329.08 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
20.15 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website nipro.co.jp
Country
Currency
JPY
Initial public offering
Feb 1, 1987
ISIN
JP3673600007
Cusip
J56655103
Sedol
6641599
Market capitalization
247.09 B JPYMega Cap
52-Week Range
PEG
2.33
P/E ratio
P/Ee 2027
14.44
P/Ee 2028
11.39
P/Ee 2029
7.98
P/Ee 2030
10.72
P/S
P/Se
0.35
EV/EBIT
20.93
P/B Ratio
0.90
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.48 %
Dividend
Dividend yield
3.05 %
Est. Dividend Yield
3.44 %
Payout Ratio
67.32 %
Dividend growth Ø5Y
9.54 %
Dividend payments per year
2
Dividend paid since
29 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
15.32 %
Last updated Oct 8, 2026, 9:35 AM

Nipro Ticker

DÜSSELDORF · 5FA.DUFRANKFURT · 5FA.FJPX · 8086.TMUNICH · 5FA.MU

Nipro FIGI

8086:JP · BBG000BFKHY68086:JT · BBG000BFKJC68086:JJ · BBG000BFKMW78086:JE · BBG000BFKPT48086:JI · BBG000BFKQ308086:JU · BBG002QK61Y68086:JW · BBG00875BFD38086JPY:X2 · BBG00JVPN3G98086JPY:XB · BBG00JVPN3H88086JPY:XH · BBG00JVPN3K48086JPY:XF · BBG00JVPN3M28086JPY:XE · BBG00JVPN3P9

All fundamentals and in-depth analysis of Nipro

Our stock analysis for Nipro stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nipro. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.